[ExpireDate]: 15-11-2021
[ExternalReference]: 2021-545747
[FtsReference]: 2021-025823
[FtsS09F02ContractNotice]
[Information]
[FtsS09F02ContractNotice]
[NoticeContract]
[Section1]: [Ca]
I.1)
[NameAddressContact]
The NHS Commissioning Board operating as NHS England - Specialised Commissioning
80 London Road
London
SE1 6LH
UK
[Contactpoint]:
Josselin Canevet
[AddressEmail]:
josselin.canevet@nhs.net
[Nutscode]:
UK -
UNITED KINGDOM
[UrlGeneral]:
https://www.england.nhs.uk/commissioning/spec-services/
[UrlBuyerprofile]:
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/68205
I.3)
[InfoTendering]
[AddressObtainDocs]:
https://uk.eu-supply.com/login.asp?B=UK[AddressFurtherinfo]
[AsContactsAbove]:
[AddressSendTendersRequest]
[AddressSendTenders]:
https://uk.eu-supply.com/login.asp?B=UK
[AddressSendTendersRequest]
[AddressToAbove]
I.4)
[CaType]
[MaintypePublicbody]
I.5)
[Mainactivity]
[MainactivHealth]
[Section2]: [Object]
II.1)
[QuantityScopeContract]
II.1.1)
[TitleContract]
Provision of Inherited White Matter Disorders Diagnostic and Management Service (IWMD) (All Ages) Re-opened from previous EU Supply Reference 45233
[Fileref]:
New Reference Number: 46264
II.1.2)
[CpvMain]
85000000
-
II.1.3)
[TypeContract]
[Services]
II.1.4)
[DescrShort]
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded.
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required and described in document 1, and within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required and described in document 1, and within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
II.1.5)
[ValueMagnitudeEstimatedTotal]
[ValueExclVat]: 1911000.00
GBP
II.1.6)
[LotsInfo]
[DivisionLots]:
[Yes]
[LotsSubmittedFor]
[LotsAll]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 1
[LotNumber]:
1
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKH -
EAST OF ENGLAND
[Nutscode]:
UKG -
WEST MIDLANDS (ENGLAND)
[Nutscode]:
UKF -
EAST MIDLANDS (ENGLAND)
[Nutscode]:
UKE -
YORKSHIRE AND THE HUMBER
[Nutscode]:
UKD -
NORTH WEST (ENGLAND)
[Nutscode]:
UKC -
NORTH EAST (ENGLAND)
II.2.4)
[DescrProcurement]
Lot 1: Adult care - one provider for the NHS England populations in the following Regions:
a. The North West;
b. The North East and Yorkshire;
c. The Midlands; and
d. The north part of the East of England Region including Cambridge
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
a. The North West;
b. The North East and Yorkshire;
c. The Midlands; and
d. The north part of the East of England Region including Cambridge
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 358000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 2
[LotNumber]:
2
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKK -
SOUTH WEST (ENGLAND)
[Nutscode]:
UKJ -
SOUTH EAST (ENGLAND)
[Nutscode]:
UKI -
LONDON
[Nutscode]:
UKH -
EAST OF ENGLAND
II.2.4)
[DescrProcurement]
Adult care: one provider for the NHS England populations in the following Regions:
a. London;
b. The South East;
c. The South West; and
d. The southern part of the East of England Region including Essex
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
a. London;
b. The South East;
c. The South West; and
d. The southern part of the East of England Region including Essex
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 392000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 3
[LotNumber]:
3
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKE -
YORKSHIRE AND THE HUMBER
[Nutscode]:
UKD -
NORTH WEST (ENGLAND)
[Nutscode]:
UKC -
NORTH EAST (ENGLAND)
II.2.4)
[DescrProcurement]
Paediatric care: one provider for the NHS England populations in the following Regions:
a. The North West; and
b. The North East and Yorkshire
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
a. The North West; and
b. The North East and Yorkshire
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 358000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 4
[LotNumber]:
4
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKH -
EAST OF ENGLAND
[Nutscode]:
UKG -
WEST MIDLANDS (ENGLAND)
[Nutscode]:
UKF -
EAST MIDLANDS (ENGLAND)
II.2.4)
[DescrProcurement]
Paediatric care: one provider for the NHS England populations in the following Regions:
a. The Midlands; and
b. The north part of the East of England Region including Cambridge
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
a. The Midlands; and
b. The north part of the East of England Region including Cambridge
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 358000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 5
[LotNumber]:
5
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UKK -
SOUTH WEST (ENGLAND)
[Nutscode]:
UKJ -
SOUTH EAST (ENGLAND)
[Nutscode]:
UKI -
LONDON
[Nutscode]:
UKH -
EAST OF ENGLAND
II.2.4)
[DescrProcurement]
Paediatric care: one provider for the NHS England populations in the following Regions:
a. London;
b. The South West;
c. The South East; and
d. The southern part of the East of England area including Essex
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
a. London;
b. The South West;
c. The South East; and
d. The southern part of the East of England area including Essex
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 392000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
Lot 6
[LotNumber]:
6
II.2.2)
[CpvAdditional]
85100000
-
85120000
-
II.2.3)
[PlacePerformance]
[Nutscode]:
UK -
UNITED KINGDOM
II.2.4)
[DescrProcurement]
One provider to host the IWMD Clinical Registry.
Note: The award of Lot 6 can only be made to a provider that is successful in one or more of Lots 1 to 5.
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
Note: The award of Lot 6 can only be made to a provider that is successful in one or more of Lots 1 to 5.
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded. Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions.
New bidders are required to submit responses to all of the questions.
The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”).
The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.
II.2.5)
[AwardCriteria]
[AwardCriteriaBelow]
[AwardCriterionQuality]
-
[AwardCriterionName]:
Quality/Technical
/
[Weighting]:
100
[Price]
-
[Weighting]:
0
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 53000.00
GBP
II.2.7)
[DurationContractFrameworkDps]
[Starting]:
01.04.2022
/
[End]:
31.03.2025
[RenewalsSubject]:
[Yes]
[RenewalsDescr]:
Commissioners have the option to extend the contract for a further 2 years.
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
[Section3]: [InfoLegal]
III.1)
[ConditionsParticip]
III.1.1)
[SituationPersonalIncl]
[InfoEvaluatingRequir]:
All professional and/or trade registrations is specified within the tender documentation.
III.1.2)
[EconomicFinancialStanding]
[InfoEvaluatingWethRequir]:
Financial standing requirements for the Procurement are outlined within Document 1 - ITT Process Overview
[MinStandardsRequired]:
Financial standing requirements for the Procurement are outlined within Document 1 - ITT Process Overview
III.1.3)
[TechnicalCapacity]
[InfoEvaluatingWethRequir]:
All technical capacity and its evaluation criteria are specified within the tender documentation.
III.2)
[ConditionsContract]
[Section4]: [Procedure]
IV.1)
[Description]
IV.1.1)
[TypeProcedure]
[ProctypeOpen]
IV.1.8)
[GpaInfo]
[GpaCovered]
: [Yes]
IV.2)
[InfoAdmin]
IV.2.2)
[LimitReceiptTendersReqPart]
[Date]:
12.11.2021
[Time]:
12:00
IV.2.4)
[LanguagesAllowed]
[Language_EN]
IV.2.6)
[MinTimeMaintain]
[DurationMonths]
: 4
([FromStatedDate])
IV.2.7)
[OpeningConditions]
[Date]:
15.11.2021
[Time]:
12:00
[Section6]: [InfoComplement]
VI.1)
[RecurrenceInfo]
[RecurrentProcurement]:
[No]
VI.4)
[AppealsProcedure]
VI.4.1)
[AppealsBody]
High Court
London
UK
VI.4.2)
[MediationBody]
High Court
London
UK
VI.4.4)
[AppealsInfo]
High Court
London
UK